Mifepristone Learning Collaborative for Community Health Centers Evaluation
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Mankato, Minnesota: 23-013015
About this study
The purpose of this study is to evaluate a program, ExPAND Mifepristone, designed and implemented by the study team. This work builds upon our previous research (IRB18-1767), “The provision of medication abortion in primary care settings in the Midwest” and (IRB20-1782), “Excellence in Providing Access to New Directions in Mifepristone Use (“ExPAND Mifepristone”): Learning Collaborative for Illinois Primary Care”.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria
- Participating ExPAND Mifepristone organization (or employee working for participating organization)
- Employees must be employed at the health center on the date of data collection
- 18 years of age or older
- Able to speak English
- Individuals participating in the Condensed Course
Exclusion Criteria
- Organizations and their employees who are not participants in the ExPAND Mifepristone learning collaborative
- Prior health center employees whose employment was terminated prior to date of data collection
- Minors (under the age of 18 years)
- Non-English speaking
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 3/20/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Mankato, Minn.
Mayo Clinic principal investigator Erin Westfall, D.O. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available